Efficacy of dapagliflozin in heart failure with reduced ejection fraction according to body mass index

Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.

PubMed · 2021 · 19.5K citations

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi et al. · New England Journal of Medicine · 2019 · 6.4K citations · Full text

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

Piotr Ponikowski, Adriaan A. Voors, Stefan D. Anker et al. · European Journal of Heart Failure · 2016 · 5.8K citations · Full text

Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure

C.Patrick Green, Charles Porter, Dennis R. Bresnahan et al. · Journal of the American College of Cardiology · 2000 · 1.8K citations

Cardiomyopathy, Heart Failure, Structural Heart Disease +5

The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update

Mandeep R. Mehra, Charles E. Canter, Margaret M. Hannan et al. · The Journal of Heart and Lung Transplantation · 2016 · 1.4K citations · Full text

Transplantation, Medicine, Outcomes Research +7